Toward miniaturized analysis of chemical identity and purity of radiopharmaceuticals via microchip electrophoresis
Miniaturized synthesis of positron emission tomography (PET) tracers is poised to offer numerous advantages including reduced tracer production costs and increased availability of diverse tracers. While many steps of the tracer production process have been miniaturized, there has been relatively little development of microscale systems for the quality control (QC) testing process that is required by regulatory agencies to ensure purity, identity, and biological safety of the radiotracer before use in human subjects. Every batch must be tested, and in contrast with ordinary pharmaceuticals, the whole set of tests of radiopharmaceuticals must be completed within a short-period of time to minimize losses due to radioactive decay. By replacing conventional techniques with microscale analytical ones, it may be possible to significantly reduce instrument cost, conserve lab space, shorten analysis times, and streamline this aspect of PET tracer production. We focus in this work on miniaturizing the subset of QC tests for chemical identity and purity. These tests generally require high-resolution chromatographic separation prior to detection to enable the approach to be applied to many different tracers (and their impurities), and have not yet, to the best of our knowledge, been tackled in microfluidic systems. Toward this end, we previously explored the feasibility of using the technique of capillary electrophoresis (CE) as a replacement for the “gold standard” approach of using high-performance liquid chromatography (HPLC) since CE offers similar separating power, flexibility, and sensitivity, but can readily be implemented in a microchip format. Using a conventional CE system, we previously demonstrated the successful separation of non-radioactive version of a clinical PET tracer, 3′-deoxy-3′-fluorothymidine (FLT), from its known by-products, and the separation of the PET tracer 1-(2′-deoxy-2′-fluoro-β-D-arabinofuranosyl)-cytosine (D-FAC) from its α-isomer, with sensitivity nearly as good as HPLC. Building on this feasibility study, in this paper, we describe the first effort to miniaturize the chemical identity and purity tests by using microchip electrophoresis (MCE). The fully automated proof-of-concept system comprises a chip for sample injection, a separation capillary, and an optical detection chip. Using the same model compound (FLT and its known by-products), we demonstrate that samples can be injected, separated, and detected, and show the potential to match the performance of HPLC. Addition of a radiation detector in the future would enable analysis of radiochemical identity and purity in the same device. We envision that eventually this MCE method could be combined with other miniaturized QC tests into a compact integrated system for automated routine QC testing of radiopharmaceuticals in the future.
KeywordsCapillary electrophoresis Microchip electrophoresis Positron emission tomography Chemical purity analysis Microfluidics Quality control testing Radiopharmaceuticals
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Ueland M, Blanes L, Taudte RV, Stuart BH, Cole N, Willis P, et al. Capillary-driven microfluidic paper-based analytical devices for lab on a chip screening of explosive residues in soil. J Chromatogr A. 2016;1436:28–33. https://doi.org/10.1016/j.chroma.2016.01.054.
- 4.D’Ambrosio MV, Bakalar M, Bennuru S, Reber C, Skandarajah A, Nilsson L, et al. Point-of-care quantification of blood-borne filarial parasites with a mobile phone microscope. Sci Transl Med. 2015;7:286re4–4. https://doi.org/10.1126/scitranslmed.aaa3480.
- 5.Phelps ME. PET: the merging of biology and imaging into molecular imaging. J NucI Med. 2000;41:661–81.Google Scholar
- 6.Bansal A, Pandey MK, Demirhan YE, Nesbitt JJ, Crespo-Diaz RJ, Terzic A, et al. Novel 89Zr cell labeling approach for PET-based cell trafficking studies. EJNMMI Res. 2015;5:19. https://doi.org/10.1186/s13550-015-0098-y.
- 7.Mariani G, Bruselli L, Kuwert T, Kim EE, Flotats A, Israel O, et al. A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging. 2010;37:1959–85. https://doi.org/10.1007/s00259-010-1390-8.
- 9.Jackson IM, Scott PJH, Thompson S. Clinical applications of radiolabeled peptides for PET. Semin Nucl Med. https://doi.org/10.1053/j.semnuclmed.2017.05.007.
- 13.Marchand P, Bekaert V, Ouadi A, Laquerriere P, Brasse D, Curien H. Forty years of 18F-labeled compound development in an open access database. J Nucl Med. 2013;54:15N–7N.Google Scholar
- 14.Radiosynthesis Database of PET Probes (RaDaP). http://www.nirs.qst.go.jp/research/division/mic/db2/. Accessed 8 May 2017.
- 15.Radiopharmaceuticals for Position Emission Tomography – Compounding. Chapter 823. Radiopharmaceuticals for position emission tomography—compounding. U. S. Pharmacopeial Conv Natl Formul. 2009; 398–406.Google Scholar
- 16.CFR - Code of Federal Regulations Title 21. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm. Accessed 30 Jun 2013.
- 17.Fermi E. Quality control of PET radiopharmaceuticals. In: Molecular imaging: radiopharmaceuticals for PET and SPECT. Berlin: Springer; 2009. p. 197–204.Google Scholar
- 18.Scott PJH, Hockley BG. Radiochemical syntheses, radiopharmaceuticals for positron emission tomography. Hoboken: Wiley; 2011.Google Scholar
- 20.Trace-ability, Inc.-SBIR Source. In: SBIRSource.com. http://sbirsource.com/sbir/firms/26162-trace-ability-inc. Accessed 26 Dec 2015.
- 22.Awasthi V, Watson J, Gali H, Matlock G, McFarland A, Bailey J, et al. A “dose on demand” biomarker generator for automated production of [18F]F- and [18F]FDG. Appl Radiat Isot. 2014;89:167–75. https://doi.org/10.1016/j.apradiso.2014.02.015.
- 23.Patabadige DE, Jia S, Sibbitts J, Sadeghi J, Sellens K, Culbertson CT. Micro total analysis systems: fundamental advances and applications. Anal Chem. 2016;88(1):320–38. https://doi.org/10.1021/acs.analchem.5b04310.
- 24.Charles River Laboratories, Inc. Endotoxin testing systems. http://www.criver.com/products-services/rapid-micro/endosafe/endotoxin-rapid-testing-systems. Accessed 16 Sep 2017.
- 25.Taggart MP, Tarn MD, Esfahani MMN, Schofield DM, Brown NJ, Archibald SJ, et al. Development of radiodetection systems towards miniaturised quality control of PET and SPECT radiopharmaceuticals. Lab Chip. 2016;16:1605–16. https://doi.org/10.1039/C6LC00099A.
- 26.Tarn MD, Isu A, Archibald SJ, Pamme N. On-chip absorbance spectroscopy for the determination of optical clarity and pH for the quality control testing of [18F]FDG radiotracer. Proceedings of the 18th International Conference on Miniaturized Systems for Chemistry and Life Sciences. October 26–30, 2014, San Antonio. 2014;1077–79.Google Scholar
- 27.Charles OC. Radioanalysis for PET imaging pharmaceuticals: on-chip detection of Kryptofix 2.2.2. Int J Sci Eng Res. 2016;7:478–94.Google Scholar
- 33.Landers JP. Handbook of capillary electrophoresis, Second Edition. Boca Raton: CRC Press; 1996.Google Scholar
- 41.Technical Data Sheet: Momentive RTV615. Momentive Performance Materials Inc. Waterford, NY. https://www.momentive.com/en-us/products/tds/rtv615/.
- 42.Engineering Note: PX2 pulsed xenon lamp stability. Ocean Optics, Inc. Dunedin, FL, USA. 8 Jul 2002. https://oceanoptics.com/wp-content/uploads/PX2-Pulsed-Xenon-Lamp-Stability.pdf.
- 43.Ocean Optics DH-2000-BAL. In: Ocean Opt. http://oceanoptics.com/product/dh-2000-bal/. Accessed 28 Dec 2015.
- 45.Pascali C, Bogni A, Fugazza L, Cucchi C, Crispu O, Laera L, et al. Simple preparation and purification of ethanol-free solutions of 3′-deoxy-3′-[18F]fluorothymidine by means of disposable solid-phase extraction cartridges. Nucl Med Biol. 2012;39:540–50. https://doi.org/10.1016/j.nucmedbio.2011.10.005.
- 46.Jorgenson JW, Lukacs KD. Zone electrophoresis in open-tubular glass capillaries. Anal Chem. 1981;53:1298–1302. https://doi.org/10.1021/ac00231a037.